Document and entity information

Jun 2021

Mar 2021

Company information

Company information

FASF member mark

true

第３四半期決算短信

Document name〔日本基準〕（連 結）

Filing date

2021-05-12

Company name

Human Metabolome

Technologies,Inc.

Securities code

6090

URL

https://humanmetabol

ome.com

Representative

Title

代表取締役社長

Name

橋爪 克仁

Inquiries

Title

取締役コーポレート

統括本部長

Name

大畑 恭宏

Tel

03-3551-2180

Other

Quarterly statement filing date (as planned)

2021-05-12

Supplemental material of quarterly results

true

Way of getting

-

Convening briefing of quarterly results

-

Target for briefing of quarterly results

-

Note to fraction processing method

（百万円未満切捨

て）

Stock exchange listings

Tokyo

true

Tokyo 1st section

-

Tokyo 2nd section

-

Tokyo Mothers

true

Tokyo JASDAQ

-

Tokyo PRO Market

-

Tokyo Others

-

Nagoya

-

Nagoya 1st section

-

Nagoya 2nd section

-

Nagoya Centrex

-

Nagoya Others

-

Sapporo

-

Sapporo

-

Sapporo Ambitious

-

Sapporo Others

-

Fukuoka

-

Fukuoka

-

Fukuoka Q-Board

-

Fukuoka Others

-

Green Sheet

-

Japan Securities Dealers Association

-

Business category

General Business

true

Specific Business

-

Fiscal Year End

2021-06-30

Quarterly period

3

Business Results-Quarterly operating results

(in millions of yens)

Mar 2021

Mar 2020

Quarterly operating results

Quarterly operating results

Consolidated operating results

Consolidated income statements information

Net sales

Net sales

926

993

% change

-6.8

-

Operating profit

Operating profit

97

128

% change

-24.0

-

Ordinary profit

Ordinary profit

118

132

% change

-10.5

-

Profit attributable to owners of parent

Profit attributable to owners of parent

93

88

% change

6.3

-

Note to consolidated income statements information

Comprehensive income

Comprehensive income

90

85

Change in comprehensive income

5.9

-

Other consolidated operating results

Basic earnings per share (Yen)

15.89

15.05

Diluted earnings per share (Yen)

15.87

15.00

Note to consolidated operating results

２．2019年６月期は

決算期変更により

15ヶ月決算となって

Note to operating results

おりますので、2020

年６月期第３四半期

の対前年四半期増減

率については記載し

ておりません。

Business Results-Quarterly financial positions

(in millions of yens)

Mar 2021

Jun 2020

Quarterly financial positions

Quarterly financial positions

Consolidated financial positions

Total assets

1,626

1,538

Net assets

1,303

1,215

Capital adequacy ratio (%)

74.3

72.6

Note to consolidated financial positions

Owner'sequity

1,208

1,117

Note to financial positions

-

Business Results-Note to quarterly business results

Mar 2021

Quarterly note to business results

Quarterly note to business results

Note to consolidated financial results

Note to consolidated financial results

-

Quarterly Dividends

(in millions of yens)

Jun 2021

Mar 2021

Jun 2020

Quarterly dividends

Quarterly dividends

Dividends

Dividend per share (Yen)

Dividend per share (Yen)

First quarter

Result

-

-

Second quarter

Result

0.00

0.00

Third quarter

Result

-

-

Year end

Result

0.00

Annual

Result

0.00

Correction of dividend forecast from the most recent dividend forecast

Correction of dividend forecast from the most recent dividend forecast

Annual

-

Note to dividends

Note to dividends

Annual

-

Quarterly Forecasts

(in millions of yens)

Jun 2021

Quarterly forecasts

Quarterly forecasts

３．2021年６月期の

Title for forecasts

連結業績予想（2020

年７月１日～2021年

６月30日）

Preamble to consolidated forecasts

Preamble to forecasts

-

Main table of consolidated forecasts

Net sales

Net sales

Forecast

1,200

Upper

-

Lower

-

% change

Forecast

7.3

Upper

-

Lower

-

Operating profit

Operating profit

Forecast

20

Upper

-

Lower

-

% change

Forecast

-

Upper

-

Lower

-

Ordinary profit

Ordinary profit

Forecast

35

Upper

-

Lower

-

% change

Forecast

-

Upper

-

Lower

-

Profit attributable to owners of parent

Profit attributable to owners of parent

Forecast

10

Upper

-

Lower

-

% change

Forecast

-

Upper

-

Lower

-

Basic earnings per share (Yen)

Basic earnings per share (Yen)

Forecast

1.69

Upper

-

Lower

-

Note to consolidated forecasts

Note to forecasts

-

Correction of financial forecast from the most recent financial forecast

Correction of financial forecast from the most recent financial forecast

Forecast

-

Notes, Quarterly-Material changes in subsidiaries during this period changes

in scope of consolidations resulting from change in subsidiaries

Mar 2021

Material changes in subsidiaries during this period (Changes in scope of consolidations resulting from change is subsidiaries)

Material changes in subsidiaries during this period (Changes in scope of consolidations resulting from change is subsidiaries)

Others

Material changes in subsidiaries during this period (Changes in scope of consolidations resulting from change is subsidiaries)

Material changes in subsidiaries during this period (Changes in

scope of consolidations resulting from change is subsidiaries)

Note to material changes in subsidiaries during this period

-

Note to material changes in subsidiaries during this period

-

Notes, Quarterly-Applying of specific accounting of the consolidated quarterly

financial statements

Mar 2021

Applying of specific accounting of the consolidated quarterly financial statements

Applying of specific accounting of the consolidated quarterly financial statements

Others

Applying of specific accounting of the consolidated quarterly financial statements

Applying of specific accounting of the consolidated quarterly

financial statements

-

Note to applying of specific accounting of the consolidated quarterly financial statements

Note to applying of specific accounting of the consolidated

quarterly financial statements

-

Notes, Quarterly-Changes in accounting policies and accounting estimates

retrospective restatement

Mar 2021

Changes in accounting policies, accounting estimates and retrospective restatement

Changes in accounting policies, accounting estimates and retrospective restatement

Others

Changes in accounting policies, accounting estimates and retrospective restatement

Changes in accounting policies based on revisions of accounting

-

standard

Changes in accounting policies other than ones based on

-

revisions of accounting standard

Changes in accounting estimates

-

Retrospective restatement

-

Note to changes in accounting policies, accounting estimates and

retrospective restatement

Note to changes in accounting policies, accounting estimates and

-

retrospective restatement

Notes, Quarterly-Number of issued and outstanding shares common stock

Mar 2021

Jun 2020

Mar 2020

Number of issued and outstanding shares (common stock)

Number of issued and outstanding shares (common stock)

Others

Number of issued and outstanding shares (common stock)

Number of issued and outstanding shares at the end of fiscal year

5,895,800

5,895,800

(including treasury stock)

Number of treasury stock at the end of fiscal year

112

112

Average number of shares

5,895,688

5,857,251

Note to number of issued and outstanding shares (common stock)

Note to number of issued and outstanding shares (common stock)

-

This information is a summary of the earnings report. It does not contain all details included in the earnings report disclosed in Japanese.

Attachments

  • Original document
  • Permalink

Disclaimer

Human Metabolome Technologies Inc. published this content on 12 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2021 13:11:05 UTC.